Brief: Aptorum Group Granted First Patent For Its SACT-1 Repurposed Drug
18/01/2022 14:54
Jan 18 (Reuters) - Aptorum Group Ltd APM.O :
* APTORUM GROUP GRANTED FIRST PATENT FOR ITS SACT-1
REPURPOSED
DRUG FOR TREATMENT OF VARIOUS CANCER INCLUDING BUT NOT LIMITED
TO NEUROBLASTOMA
Source text for Eikon: ID:nBw2CxGVFa
Further company coverage: APM.O
Recent news on Aptorum
See all newsBrief: Niki Biosolutions Signs Agreement To Supply Apoe Genotyping To Charter Research
NASDAQ RESUMED AT 10:24 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:19 AM
Niki BioSolutions weighs financing options as going-concern warning clouds post-merger outlook
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM